1. Home
  2. AMPS vs KROS Comparison

AMPS vs KROS Comparison

Compare AMPS & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPS
  • KROS
  • Stock Information
  • Founded
  • AMPS 2009
  • KROS 2015
  • Country
  • AMPS United States
  • KROS United States
  • Employees
  • AMPS N/A
  • KROS N/A
  • Industry
  • AMPS Electric Utilities: Central
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMPS Utilities
  • KROS Health Care
  • Exchange
  • AMPS Nasdaq
  • KROS Nasdaq
  • Market Cap
  • AMPS 608.0M
  • KROS 589.8M
  • IPO Year
  • AMPS N/A
  • KROS 2020
  • Fundamental
  • Price
  • AMPS $3.74
  • KROS $11.84
  • Analyst Decision
  • AMPS Strong Buy
  • KROS Buy
  • Analyst Count
  • AMPS 9
  • KROS 11
  • Target Price
  • AMPS $5.38
  • KROS $45.33
  • AVG Volume (30 Days)
  • AMPS 1.0M
  • KROS 2.1M
  • Earning Date
  • AMPS 03-13-2025
  • KROS 02-26-2025
  • Dividend Yield
  • AMPS N/A
  • KROS N/A
  • EPS Growth
  • AMPS N/A
  • KROS N/A
  • EPS
  • AMPS 0.22
  • KROS N/A
  • Revenue
  • AMPS $185,992,000.00
  • KROS $651,000.00
  • Revenue This Year
  • AMPS $30.56
  • KROS $303.27
  • Revenue Next Year
  • AMPS $17.93
  • KROS N/A
  • P/E Ratio
  • AMPS $16.98
  • KROS N/A
  • Revenue Growth
  • AMPS 25.90
  • KROS 8037.50
  • 52 Week Low
  • AMPS $2.71
  • KROS $9.78
  • 52 Week High
  • AMPS $7.28
  • KROS $73.00
  • Technical
  • Relative Strength Index (RSI)
  • AMPS 45.89
  • KROS 24.87
  • Support Level
  • AMPS $3.82
  • KROS $10.95
  • Resistance Level
  • AMPS $4.24
  • KROS $11.63
  • Average True Range (ATR)
  • AMPS 0.28
  • KROS 0.87
  • MACD
  • AMPS -0.06
  • KROS 1.31
  • Stochastic Oscillator
  • AMPS 36.14
  • KROS 30.60

About AMPS Altus Power Inc.

Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: